• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives N-alkylindoles

Professional Introduction to (1-Methyl-1H-indol-2-yl)boronic Acid (CAS No. 191162-40-0)

(1-Methyl-1H-indol-2-yl)boronic acid is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This boronic acid derivative, identified by the CAS number 191162-40-0, has garnered considerable attention due to its role in the synthesis of various biologically active molecules. The compound’s molecular structure, featuring a boronic acid functional group attached to a methyl-substituted indole ring, makes it a valuable intermediate in organic synthesis, particularly in cross-coupling reactions such as the Suzuki-Miyaura coupling.

The utility of (1-Methyl-1H-indol-2-yl)boronic acid in medicinal chemistry stems from its ability to participate in palladium-catalyzed reactions, which are pivotal in constructing complex molecular frameworks. Boronic acids are known for their high reactivity and compatibility with transition metals, making them indispensable in the development of novel therapeutic agents. Recent advancements in synthetic methodologies have further highlighted the importance of this compound, particularly in the context of drug discovery and development.

In recent years, research has demonstrated the potential of (1-Methyl-1H-indol-2-yl)boronic acid in the synthesis of indole-based pharmaceuticals. Indole derivatives are widely recognized for their pharmacological properties, including antimicrobial, anti-inflammatory, and anticancer activities. The incorporation of a boronic acid moiety into these structures enhances their reactivity and allows for further functionalization, enabling the creation of more sophisticated drug candidates.

One notable application of (1-Methyl-1H-indol-2-yl)boronic acid is in the development of targeted therapies for cancer. Researchers have leveraged its participation in Suzuki-Miyaura cross-coupling reactions to generate novel indole-based inhibitors that selectively target cancer cells. These inhibitors have shown promise in preclinical studies, demonstrating mechanisms that disrupt critical signaling pathways involved in tumor growth and progression. The ability to precisely modify the indole core using boronic acid intermediates has opened new avenues for designing next-generation anticancer drugs.

The role of (1-Methyl-1H-indol-2-yl)boronic acid extends beyond oncology; it has also been explored in the treatment of neurological disorders. Indole derivatives are known to interact with various neurotransmitter systems, making them potential candidates for drugs targeting conditions such as depression, anxiety, and neurodegenerative diseases. The boronic acid functional group provides a versatile handle for further chemical manipulation, allowing researchers to fine-tune the pharmacological properties of these compounds. Recent studies have reported on the synthesis of indole-based ligands that modulate GABAergic and glutamatergic receptors, highlighting the therapeutic potential of this class of molecules.

In addition to its pharmaceutical applications, (1-Methyl-1H-indol-2-yl)boronic acid has found utility in materials science. The unique electronic properties of boronic acids make them suitable for use in organic electronics, including organic light-emitting diodes (OLEDs) and photovoltaic devices. Researchers have utilized this compound to develop new materials with enhanced luminescent and conductive properties. The ability to integrate boronic acid functionalities into organic semiconductors has opened up possibilities for innovative applications in display technologies and energy storage systems.

The synthesis of (1-Methyl-1H-indol-2-yl)boronic acid has been optimized through various methodologies to ensure high yields and purity. Traditional approaches involve halogenation followed by lithiation-borylation sequences, but recent advances have introduced more efficient and sustainable synthetic routes. For instance, catalytic borylation methods have been developed that minimize waste and reduce reaction times without compromising product quality. These innovations align with the growing emphasis on green chemistry principles in industrial-scale production.

The chemical reactivity of (1-Methyl-1H-indol-2-yl)boronic acid allows for diverse functionalizations, making it a cornerstone in synthetic organic chemistry. Its participation in cross-coupling reactions enables the construction of complex heterocyclic frameworks, which are prevalent in many natural products and drug candidates. The versatility of this compound has been demonstrated through its use in synthesizing biologically active molecules such as kinase inhibitors and antiviral agents.

In conclusion, (1-Methyl-1H-indol-2-yl)boronic acid (CAS No. 191162-40-0) is a multifaceted compound with significant implications across pharmaceuticals, materials science, and organic synthesis. Its unique structural features and reactivity make it an invaluable tool for researchers seeking to develop novel therapeutic agents and advanced materials. As our understanding of its applications continues to evolve, so too will its role in driving innovation within these fields.

• 912331-34-1(B-(5-chloro-1-methyl-1H-indol-2-yl)-Boronic acid)
• 912331-40-9(B-(6-fluoro-1-methyl-1H-indol-2-yl)-Boronic acid)
• 220396-46-3((1H-Indol-2-yl)boronic acid)
• 911318-81-5((1-Methyl-1H-pyrrol-2-yl)boronic acid)
• 745784-12-7(Quinolin-2-ylboronic acid)
• 912331-36-3(B-(4-fluoro-1-methyl-1H-indol-2-yl)-Boronic acid)
• 912331-32-9(B-(4-chloro-1-methyl-1H-indol-2-yl)-Boronic acid)
• 912331-38-5(B-(5-fluoro-1-methyl-1H-indol-2-yl)-Boronic acid)
• 957066-11-4(6-Chloro-1-methylindole-2-boronic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)